Cargando…

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies

AIMS: An algorithm for non‐invasive diagnosis of amyloid transthyretin cardiac amyloidosis (ATTR‐CA) and novel disease‐modifying therapies have prompted an active search for CA. We examined the prevalence of CA in different settings based on literature data. METHODS AND RESULTS: We performed a syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aimo, Alberto, Merlo, Marco, Porcari, Aldostefano, Georgiopoulos, Georgios, Pagura, Linda, Vergaro, Giuseppe, Sinagra, Gianfranco, Emdin, Michele, Rapezzi, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd. 2022
Materias:	Cardiac Amyloidosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084346/ https://www.ncbi.nlm.nih.gov/pubmed/35509173 http://dx.doi.org/10.1002/ejhf.2532

Ejemplares similares

Value of the HFA‐PEFF and H(2)FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
por: Chacko, Liza, et al.
Publicado: (2022)

Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis
por: Patel, Rishi K., et al.
Publicado: (2022)

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Klaassen, Sebastiaan HC, et al.
Publicado: (2020)

Systemic embolism in amyloid transthyretin cardiomyopathy
por: Vilches, Silvia, et al.
Publicado: (2022)

Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value
por: Cipriani, Alberto, et al.
Publicado: (2022)

Re-Definition of the Epidemiology of Cardiac Amyloidosis
por: Rossi, Maddalena, et al.
Publicado: (2022)

Restrictive cardiomyopathy: definition and diagnosis
por: Rapezzi, Claudio, et al.
Publicado: (2022)

Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination
por: Porcari, Aldostefano, et al.
Publicado: (2021)

Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery
por: Porcari, Aldostefano, et al.
Publicado: (2020)

Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Regression of the Anatomic Cardiac Features of Amyloid Light Chain Cardiac Amyloidosis Accompanied by Normalization of Global Longitudinal Strain
por: Fitzgerald, Benjamin T., et al.
Publicado: (2017)

An Autopsy Case of Cardiac Amyloidosis with Heterogeneous Deposition of Amyloid Protein: A Possible Mechanism for Relative Apical Sparing of Longitudinal Strain
por: Sawada, Naoko, et al.
Publicado: (2019)

Transthyretin Cardiac Amyloidosis: A Noninvasive Multimodality Approach to Diagnosis Using Transthoracic Echocardiography, 99m-Tc-Labeled Phosphate Bone Scanning, and Cardiac Magnetic Resonance Imaging
por: Shukla, Akhil, et al.
Publicado: (2017)

Cardiac amyloidosis: do not forget to look for it
por: Porcari, Aldostefano, et al.
Publicado: (2020)

Editorial: Proceedings and predictions in cardiac amyloidosis: unsolved mysteries and challenges for the future
por: Porcari, Aldostefano, et al.
Publicado: (2023)

Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2020)

Atrial amyloidosis: mechanisms and clinical manifestations
por: Vergaro, Giuseppe, et al.
Publicado: (2022)

Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery
por: Porcari, Aldostefano, et al.
Publicado: (2021)

Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
por: Gonzalez-Lopez, Esther, et al.
Publicado: (2022)

Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis
por: Morfino, Paolo, et al.
Publicado: (2022)

Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis
por: Emdin, Michele, et al.
Publicado: (2023)

Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Exploring the possible link between myocarditis and mRNA COVID-19 vaccines
por: Sinagra, Gianfranco, et al.
Publicado: (2021)

Role of Daratumumab in Cardiac AL Amyloidosis
por: Gertz, Morie A.
Publicado: (2022)

A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation
por: Nuzzi, Vincenzo, et al.
Publicado: (2023)

Immunoglobulin light chain amyloidosis presenting as Budd-Chiari syndrome
por: Ozercan, Mubin, et al.
Publicado: (2021)

Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
por: Vergaro, Giuseppe, et al.
Publicado: (2021)

Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial
por: Minnema, Monique C., et al.
Publicado: (2022)

Tissue Characterization in Cardiac Amyloidosis
por: Musetti, Veronica, et al.
Publicado: (2022)

Cardiovascular toxicity from therapies for light chain amyloidosis
por: Morfino, Paolo, et al.
Publicado: (2023)

AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review
por: Wechalekar, Ashutosh D., et al.
Publicado: (2022)

Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance
por: Martini, Nicola, et al.
Publicado: (2020)

Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis
por: Pucci, Angela, et al.
Publicado: (2021)

One-Year Risk of Myocarditis After COVID-19 Infection: A Systematic Review and Meta-analysis
por: Zuin, Marco, et al.
Publicado: (2023)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Longitudinal strain in the management of cardiac AL amyloidosis: do we need it?
por: Rapezzi, Claudio, et al.
Publicado: (2021)

Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2021)

Biomarkers for the diagnosis and management of heart failure
por: Castiglione, Vincenzo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tkrmlq9r41dfocmiglua6vi8hi